UK Police to Evaluate Train Operators on Sexual Harassment Measures Government Confirms No Financial Penalties for NonCompliance Kazatomprom Reports 17 Production Increase in Q3 Signals Strong Uranium Output Meta Agrees to Settle Social Media Addiction Lawsuit with US School District Case Was Bellwether for Hundreds of Similar Claims Nvidia Reports Another Strong Quarter Revenue Surges 85 to 816 Billion in Fiscal Q1 Signos Secures 20M Funding Deepens Dexcom Partnership to Capitalize on GLP1 WeightLoss Trend JPMorgan Adjusts HP Inc Price Target Ahead of Quarterly Earnings BORR Q1 2026 Earnings EPS Falls Short of Estimates by a Wide Margin Duke Energy DUKB Q1 2026 Earnings Adjusted EPS Beats Estimates Amid Steady Utility Performance AZTR Q1 2026 Earnings Significant EPS Miss and Stock Decline Amid PreRevenue Stage Ashland Inc Q1 2026 Earnings EPS Misses Estimates as Stock Gains Modestly MDLZ Q1 2026 Earnings EPS Beats Estimates by 81 as Snacking Giant Navigates Cost Pressures XFOR Q1 2026 Earnings EPS Beats Estimates Despite Continued PreRevenue Status Stock Declines Allarity Therapeutics ALLR Surges 66 as Volume Picks Up Testing Key Resistance DIAX Edges Lower as Options Overwrite Fund Navigates Support and Resistance Tempus AI Inc TEM Modestly Higher as It Holds Near Key Support AGI Inc AGBK Slides 084 as Investors Weigh NearTerm Challenges Orthofix Medical OFIX Drops 9 as Stock Tests Key Support Near 928 GLRE Q1 2026 Earnings Strong Profitability Drives Positive Market Response Biomea Fusion Inc BMEA Q1 2026 Earnings EPS Surprise of Nearly 30 Drives Positive Market Response RAPP Q1 2026 Earnings Narrower Loss Beats Street Estimates as PreRevenue Biotech Advances Pipeline iHeartMedia Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick Ashland Inc ASH Q1 2026 Earnings EPS Misses Estimates Stock Gains Slightly BTI Q4 2025 Earnings EPS Beats Estimates Amid Modest Stock Decline Japans Megabanks Report Record Profits Amid Rising Credit and Geopolitical Risks RBKB Q1 2026 Earnings EPS of 020 Reported Amid Stock Decline Precision BioSciences DTIL Jumps 484 as Biotech Sentiment Improves